Greatbatch, Inc. announced the qualification of its first battery model to incorporate nanoSVOTM for use in next-generation implantable medical devices.
This announcement marks a dramatic advancement in the clinically-proven Silver Vanadium Oxide (SVO) high-rate battery product line. nanoSVO™ results from a proprietary, highly efficient synthesis process that vastly improves cathode material homogeneity, yielding more reliable and superior battery performance. The qualification of this novel cathode manufacturing process represents the successful integration of Greatbatch’s commercialization expertise and the intellectual property gained from the acquisition of NanoGram Devices Corporation in 2004.
Susan Campbell, Vice President of Medical Power for Greatbatch, stated, “We are committed to providing the most reliable implantable medical components available. The qualification of nanoSVO™ is a validation of the Greatbatch intellectual property investment strategy and is consistent with our history of delivering the technology necessary to enhance performance and reliability for our customers.”